Schonfeld Strategic Advisors LLC Argenx Se Transaction History

Schonfeld Strategic Advisors LLC

$15 Billion
Q1 2025

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$520.52 - $638.33 $2.79 Million - $3.43 Million	5,368 New	5,368 $3.3 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $3.31 Million - $4.2 Million	-9,301 Reduced 75.0%	3,100 $1.33 Million
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $4.43 Million - $5.13 Million	12,401 New	12,401 $4.88 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $5.74 Million - $8.53 Million	15,545 Added 421.62%	19,232 $9.46 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $2.29 Million - $2.68 Million	-6,353 Reduced 63.28%	3,687 $1.44 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $5.63 Million - $6.8 Million	-16,842 Reduced 62.65%	10,040 $3.74 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $9.2 Million - $10.8 Million	26,882 New	26,882 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $1.16 Million - $1.63 Million	4,306 Added 193.35%	6,533 $2.47 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $938,666 - $1.3 Million	-3,689 Reduced 62.36%	2,227 $702,000
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $1.61 Million - $2.09 Million	5,916 New	5,916 $2.07 Million
Q3 2021 Nov 16, 2021	SELL	$295.0 - $350.58 $973,500 - $1.16 Million	-3,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $848,463 - $1.06 Million	3,300 New	3,300 $994,000
Q2 2020 Aug 14, 2020	SELL	$127.44 - $232.72 $267,624 - $488,712	-2,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $228,543 - $346,983	2,100 New	2,100 $277,000
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $319,770 - $492,630	-3,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$113.31 - $150.51 $4.46 Million - $5.93 Million	-39,400 Reduced 92.92%	3,000 $342,000
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $4.88 Million - $6 Million	42,400 New	42,400 $6 Million
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $2.79 Million - $3.8 Million	-28,200 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $1.2 Million - $2.06 Million	18,800 Added 200.0%	28,200 $2.71 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $67,950 - $86,967	900 Added 10.59%	9,400 $713,000
Q2 2018 Aug 14, 2018	SELL	$74.84 - $100.16 $4.32 Million - $5.78 Million	-57,709 Reduced 87.16%	8,500 $704,000
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $2.58 Million - $3.86 Million	45,326 Added 217.05%	66,209 $5.33 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $471,329 - $1.33 Million	20,883	20,883 $1.32 Million

Others Institutions Holding ARGX

# of Institutions

498

Shares Held

28.6M

Call Options Held

331K

Put Options Held

226K

Price T Rowe Associates Inc Baltimore, MD

5.38M
Shares

$3.43 Billion
0.39% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

2.79M
Shares

$1.78 Billion
2.84% of portfolio
Janus Henderson Group PLC London, X0

2.14M
Shares

$1.37 Billion
0.73% of portfolio
Capital World Investors Los Angeles, CA

1.95M
Shares

$1.24 Billion
0.16% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$787 Million
11.83% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account